Atlas Trials

Stellate Ganglion Blockade for Refractory Chronic Migraine

Clinical trial NCT06891118 · COMPLETED

Trial details

NCT number
NCT06891118
Sponsor
Ankara City Hospital Bilkent
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Headache, MigraineChronic Migraine Headache
Start date
2024-03-06
Primary completion
2025-12-30
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.